Sign in
Taking people in United StatesNo phase

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Key facts

Who runs it
Boston University
Where
Boston, Minneapolis, and Philadelphia, United StatesSee the 3 sites
Trial code
Status
Recruiting
People taking part
172 people, planned
Started
15 Sept 2025
Expected to end
Jan 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • RISE
  • Advocacy-based ECAU
Record updated
30 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
  • report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
  • be able to provide informed consent including permission to have intervention sessions recorded

Who cannot take part

  • severe cognitive impairment,
  • suicide or homicide intent with a specific plan
  • untreated or unstable symptoms of mania or psychosis

This trial is currently available in United States.

  • VA Boston Healthcare SystemBoston, United StatesContact: Katherine M Iverson, PhDTaking people
  • VA Minneapolis Healthcare SystemMinneapolis, United StatesContact: Princess Ackland, PhDTaking people
  • VA Philadelphia Healthcare SystemPhiladelphia, United StatesContact: Melissa Dichter, PhDTaking people

About the trial

What the trial wants to find out

This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health.

Read full original descriptionShow less

Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.

The 2 groups in the trial

  • RISE (Recovering from Intimate Partner Violence through Strengths and Empowerment)Treatment being tested

    Participants randomized to the RISE arm will have 1 or more RISE sessions.

    Treatment: RISE

  • Advocacy-based ECAU (Enhanced Care as Usual)Existing treatment, for comparison

    Participants randomized to this arm will have a single Advocacy-based ECAU session

    Treatment: Advocacy-based ECAU

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Recovering From IPV Through Strengths and Empowerment (RISE) Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
Record updated
30 September 2026